Results 161 to 170 of about 24,764 (229)
An Economic Evaluation of a Streamlined Day-Case Atrial Fibrillation Ablation Protocol and Conventional Cryoballoon Ablation versus Antiarrhythmic Drugs in a UK Paroxysmal Atrial Fibrillation Population. [PDF]
Pharmacoecon OpenMoss JWE +17 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Treatment Options in Cardiovascular Medicine, 2004
Both supraventricular and ventricular arrhythmias are associated with increased mortality and morbidity. Numerous antiarrhythmics have been developed in an attempt to decrease the frequency of these arrhythmias, hoping to improve survival and improve quality of life.
Steven N., Singh +2 more
openaire +2 more sources
Both supraventricular and ventricular arrhythmias are associated with increased mortality and morbidity. Numerous antiarrhythmics have been developed in an attempt to decrease the frequency of these arrhythmias, hoping to improve survival and improve quality of life.
Steven N., Singh +2 more
openaire +2 more sources
Classification of Antiarrhythmic Drugs
The Journal of Clinical Pharmacology, 1989Although many classification schemes for antiarrhythmic drugs have been proposed, the system introduced by Vaughan Williams and later modified by Harrison has been widely accepted. This classification system is comprised of four categories. Class I agents block sodium channels. Class II agents are Beta blockers.
H, Frumin, N Z, Kerin, M, Rubenfire
openaire +2 more sources
Antiarrhythmic drugs and epilepsy
Pharmacological Reports, 2014For a long time it has been suspected that epilepsy and cardiac arrhythmia may have common molecular background. Furthermore, seizures can affect function of the central autonomic control centers leading to short- and long-term alterations of cardiac rhythm. Sudden unexpected death in epilepsy (SUDEP) has most likely a cardiac mechanism.
Kinga K, Borowicz, Monika, Banach
openaire +2 more sources